AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

Recruitingn/aAges 30 Years - 85 YearsAllChinese University of Hong Kong
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Inclusion Criteria for the Symptomatic Group: 1. Patient is 30 to 85 years of age, inclusive. 2. Patients who have an acute infarct in diffusion-weighted MRI compatible with artery-to-artery thrombo-embolism, a relevant intracranial atherosclerotic stenosis โ‰ฅ60%, and MES detected by TCD. 3. Patient who has no contra-indication for the proposed imaging tests. 4. Patient understands the purpose and requirements of the study, and has provided an informed consent. * Inclusion Criteria for the Asymptomatic Group: 1. Patient is 30 to 85 years of age, inclusive. 2. Patient who has a high-grade (\>60%) intracranial stenosis (signal void in MR angiography) but without infarct in the corresponding vascular territory in DWI or T2-weighted sequence. 3. Patient has no MES detected on TCD examination. 4. Patient who has no contra-indication for the proposed imaging tests. 5. Patient understands the purpose and requirements of the study, and has provided an informed consent. Exclusion Criteria: Subject who meets one or more of the following criteria cannot be recruited in the study: 1. Stroke etiology uncertain or unrelated to intracranial atherosclerosis, such as cardioembolism, Moyamoya disease, small vessel disease, etc. 2. A tandem stenosis \>50% at proximal internal carotid artery. 3. Bleeding propensity: active peptic ulcer disease, major systemic hemorrhage within 30 days, thrombocytopenia (platelets \<100 x 109/L), coagulopathy (INR \>1.5). 4. A medical condition that would not allow the patient to adhere to the protocol or complete the study.
๐Ÿ’Š

What it tests

  • DSA/3DRA
๐Ÿ“

Where

1 site
Chinese University of Hong Kong
Hong Kong, Hong Kong
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy